Sunday, 2 June 2013

Experimental Drug Shows Benefits Against Melanoma in Early Study

Lambrolizumab activates body's immune system to kill cancerous cells, researchers say via Resurrection Health Care - Daily News More READ

No comments:

Post a Comment